hepatitis C

News

NHS trumpets Hep C deal, quietly drops 2025 elimination targ...

NHS England has announced a deal with AbbVie, Gilead, and Merck, Sharpe and Dohme (MSD) that aims to eliminate hepatitis C from the country - although it has had to drop a 2025 target

News

Hepatitis Virus - 3d rendered illustration

Court backs NHS in hepatitis C procurement row with AbbVie

A court has backed NHS England in a case where US pharma giant AbbVie had alleged that its procurement process for hepatitis C drugs was unfair.

News

Gilead launches generics of own hepatitis C drugs in US to c...

Gilead is to launch cheaper generic versions of its hepatitis C drugs in the US, responding to calls for lower drug prices because of spiralling healthcare costs.

News

Hepatitis drug wins award for cure rate and efficacy

Hepatitis C drug Ganovo won a top clinical research award due to its successful performance in a phase 3 trial.

News

Gilead takes 'HIV eradication' combo into clinic

New approach tackles reserve of HIV within the body

News

Hep C woes to continue - but Gilead willing to acquire again

Gilead recorded a loss of $3.9 billion in Q4 because of a one-off charge linked to US tax reforms – however it has bigger problems because of the decline in its hepatitis C portfolio.<

NHS trumpets Hep C deal, quietly drops 2025 elimination targ...

Court backs NHS in hepatitis C procurement row with AbbVie

Gilead launches generics of own hepatitis C drugs in US to c...

Hepatitis drug wins award for cure rate and efficacy

Gilead takes 'HIV eradication' combo into clinic

Hep C woes to continue - but Gilead willing to acquire again

Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer

Discover a new era of healthcare panel engagement: Grounded ...

hepatitis C

Editor's Picks